7.10.2025
Merz Therapeutics Expands Presence with New Affiliate in Poland
Read more
We’re taking specialty neurology further
Our work in neurology
We’re thinking bigger
Learn about our science
We’re a family business with a global purpose.
Learn about Merz Therapeutics
Merz Therapeutics Expands Presence with New Affiliate in Poland
Read article
Company
What defines us
Our mission is to deliver better outcomes for more patients. And it’s those two powerful words that define us today.
Better – because our portfolio of neurology, hepatology and dermatology therapies is complemented by a pipeline of innovation that will help us continue to achieve better outcomes in new areas.
More – because our strategy of growth has the simple, essential goal of making our therapies available to anyone around the world who needs them.
Neurology
Regaining control
With our medicines, we aim to contribute to improving the quality of life of patients with neurological disorders such as Parkinson’s disease, Multiple Sclerosis, Dystonia, Spasticity, Sialorrhea, Alzheimer’s disease, and vocal fold insufficiency.
Learn about how we are helping Neurology patients' lives
Dermatology
Happy in our own skin
First impressions count, which is why skin and hair are such vital parts of our appearance. We help patients feel comfortable in their skin again, with medicines that can help people with scarring or who are experiencing hair loss. By supporting people with their outside appearance, we can help make profound improvements to how they feel inside.
Learn about how we are helping Dermatology patients' lives
Hepatology
Protecting what protects us
Our livers are central to the balance of our health, regulating our protein, fat and sugar metabolism as well as mineral, vitamin and hormone balance. Chronic Liver Disease, where the function of the liver worsens over time, is therefore an urgent medical priority in those affected. We’re proud to provide treatment options in this area.
Learn about how we are helping Hepatology patients' lives
Partnering
Working with Merz Therapeutics
Partnership is central to our growth strategy. To deliver better outcomes for more patients, we must constantly be forging new connections with like-minded organizations and individuals.
Partnership means many things: from strategic acquisitions to academic collaboration, we are actively seeking new opportunities in all aspects.
We’ll hope to hear from you soon.
Read more about our strategy of growth here
Transform Neuroscience with us
Committed to successful collaboration
Partnering put into practice
With 2 production sites, offices in 12 countries and sales in over 80 countries, we recognise the significant impact our business has on the environment and society.
We established a formal Sustainability Strategy in 2021 as part of our commitment to improving health in the markets we serve. This strategy, under constant review and refinement, is now a central consideration when making choices about how to deliver better outcomes for more patients.
You can read more about our Sustainability Strategy, and the tangible steps we are taking to operate as responsibly as possible, here.
As a 117 year-old, family-owned company, we’re immediately a “different” workplace within our sector. But what does that really mean?
Our close-knit culture means we’re as passionate about our own team as we are about the people whose needs we serve. Everyone who works for us has the power and support to propose new ideas and set a bold course for their career. And our focus on creating and nurturing diverse workplaces worldwide is already having a positive impact on how we operate and what we’re achieving.
Our impact
Making things better
starts with ourselves.
We are committed to making a positive impact with every footstep. For our people, for our patients and for our planet, we seek to operate by example. Here are some of the ways we’re improving the lives we reach, and world we work in.
68%
of Merz Therapeutics Employees were women in 2023
56.2%
average waste recovery rate
2024
publication of our first sustainability report
